For the past 2 decades, MBRI has been exclusively dedicated to the areas of animal cell culture and blood cell isolation, and has earned a reputation for quality and service in this field. Based upon our vast experience, a Cord Blood Bank has been launched to offer alternative therapies that could treat various incurable diseases such as cancers and hematological malignancies, by supplementing or replacing bone marrow transplantation.

Life Line was established in April 2003 and has been conducting Cord Blood business as the leading CB bank in Korea. Two non-profit institutes are involved in this business; Mogam Biotechnology Research Institute (MBRI) and Green Cross Reference Laboratory (GCRL). MBRI is responsible for both processing and cryopreservation with a substantial long-term commitment to innovative therapeutic and clinical applications. GCRL, one of the best clinical reference centers in Korea, is conducting CB collection and serological/genetic tests including HLA typing and establishing a database for cord blood.

Diseases treated by CB transplantation
• Standard therapy
• Leukemia ; Acute leukemia, Chronic leukemia
• Myelodysplastic Syndromes, Lymphomas
• Severe aplastic anemia
• Multiple myeloma, Plasma cell leukemia
• Cancers ; Neuroblastoma

Therapies in clinical trials
• Cancerous tumors ; Breast cancer, renal cell carcinoma
• Hurler⡯s syndrome, Gauchers disease
• Multiple Sclerosis, Diabetes type I
• Rheumatoid Arthritis, Parkinsons disease
• Alzheimers disease, Huntingtons disease

MBRI Awarded ISO 9001:2000 Quality Management System Certification
December 2004, TUV Management Service GmbH, leading ISO accreditation firm based in Germany , certified MBRI as ISO 9001:2000 compliant. The certification covers Cord Blood business including the Processing, Preserving and Providing of Cord Blood.
The designation provides additional assurance, from an independent body, to customers and business partners that MBRI has the systems and procedures in place to provide services of consistently high quality. It also represents MBRI's ongoing commitment to quality and continuous improvement in the Cord Blood Bank business. The certification is expected; 1) to improve our customers' satisfaction, 2) to restore the confidence of our customers, and 3) to increase our responsiveness to customer needs and requirements.

About ISO 9001
ISO 9001 was founded in 1987 as an internationally-accepted quality management certification system to define, identify and confirm quality benchmarks. Today, ISO 9001 is helping thousands of companies worldwide manage their processes to become more efficient and cost-effective. The most recent change to the ISO 9001 standard is ISO 9001:2000.